Rasburicase is limited to a single, fixed dose for prophylaxis or treatment of hyperuricemia based on the following parameters:
Uric acid level < 15 mg/dL - single dose not to exceed 3 mg
Uric acid level > 15 mg/dL - single dose not to exceed 7.5 mg
Pharmacist may round dose in accordance with the parameters above "per policy"
A second dose may be administered if hyperuricemia persists after 24 hours in accordance with the parameters above
Uric acid levels should be monitored at baseline, 4 hours after administration, and then every 6-8 hours until tumor lysis syndrome resolution "per policy"
Order verifying pharmacist shall notify the pharmacy clinical specialist of rasburicase orders not in accordance with this policy
Policies and procedures
Policy and Procedure System_RXCLIN 107 Rasburicase Fixed-Dose Policy
Key Points:
Consults, protocols, and therapeutic interchanges
Additional information